In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
Boston-based Life Biosciences is testing whether reprogramming human cells can slow or even reverse the effects of aging. Unsplash Life Biosciences, a Boston-based biotechnology company founded in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results